Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MMSTabs appears to be a small private company operating the mmstabs.com website and selling so-called MMS products directly to consumers. Publicly available evidence links the business to the name Jim Humble Vision Products and to Terance Winson, with operations associated with Cape Town, South Africa. The company is not a conventional biotech or pharmaceutical developer with a disclosed therapeutic pipeline, clinical-stage assets, or validated R&D platform. Instead, it appears to be a commercial seller of alternative health products, and U.S. regulators previously issued a warning letter regarding unapproved and misbranded products marketed with COVID-19-related claims. For biotech diligence purposes, MMSTabs is better characterized as a consumer product/alternative-health vendor than as a drug development company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MMSTabs.